Milan, Italy

Carlo Gorini


Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1989-1992

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Carlo Gorini: Innovator in Pharmaceutical Chemistry

Introduction

Carlo Gorini is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating muscle spasms. With a total of seven patents to his name, Gorini's work has the potential to impact the medical community positively.

Latest Patents

Gorini's latest patents include derivatives of 1-arylsulphonyl-2-pyrolidinone. These compounds are designed for the treatment of patients suffering from muscle spasms. The formula involves various radicals and components that enhance the therapeutic efficacy of the compounds. His innovative approach to these derivatives showcases his commitment to advancing medical treatments.

Career Highlights

Throughout his career, Carlo Gorini has been associated with Roussel Uclaf, a company known for its focus on pharmaceutical research and development. His work has led to the creation of valuable therapeutic compositions that address specific medical needs. Gorini's expertise in the field has established him as a respected figure among his peers.

Collaborations

Gorini has collaborated with notable coworkers such as Emilio Toja and Fernando Barzaghi. These partnerships have contributed to the successful development of his patented compounds and have fostered a collaborative environment for innovation.

Conclusion

Carlo Gorini's contributions to pharmaceutical chemistry through his innovative patents demonstrate his dedication to improving patient care. His work continues to inspire advancements in the treatment of muscle spasms and highlights the importance of research in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…